Sentinel node biopsy is a minimally invasive surgical procedure that is used for staging of breast cancer and melanoma. It involves the injection of a radioactive substance and/or dye near the tumor, which then travels to the sentinel lymph nodes - the first lymph nodes that drain lymph fluid from the tumor site. These sentinel nodes are then removed and examined to detect the presence of cancer cells. If sentinel nodes are free of cancer, it is less likely that cancer has spread to other lymph nodes.
The global sentinel node biopsy market size is estimated to reach US$ 1,209.2 million by 2031 registering a CAGR of 7.0% over the forecast period.
Sentinel Node Biopsy Market Growth is rise in prevalence of breast cancer and melanoma globally is the key driver for sentinel node biopsy procedures. According to WHO, breast cancer is the most common cancer in women with an estimated 2.3 million new cases and 685,000 deaths in 2020. Melanoma skin cancer is also on rise owing to increased exposure to UV rays. Sentinel node biopsy offers advantages over conventional lymph node dissection as it is less invasive with reduced risk of lymphedema and nerve damage.
Key Takeaways
Key players operating in the sentinel node biopsy market are Hologic, Inc., Stryker Corporation, Devicor Medical Products, Inc., Boston Scientific Corporation, KUBTEC Medical Imaging, LabLogic Systems Ltd., SurgicEye GmbH, CareWise Health, Navidea Biopharmaceuticals, Inc., Intramedical Imaging, LLC, GE Healthcare, Siemens Healthineers, Philips Healthcare, Medtronic, and C. R. Bard, Inc.
Demand for sentinel node biopsy is growing owing to rising incidence of breast cancer and melanoma globally. According to WHO, breast cancer new cases are projected to increase by over 50% globally by 2040.
Technological advancements are being made to develop tracers, imaging systems, and techniques to improve accuracy and reduce false negatives in sentinel node biopsy. Use of combinations of radiotracers such as Technetium-99m with blue dye is gaining popularity.
Market Trends
Increased preference for minimally invasive surgeries - Sentinel node biopsy is minimally invasive as compared to lymph node dissection, resulting in fast recovery and reduced risk of complications.
Integration of robotics and navigation systems - Technologies such as fluorescence imaging, radiofrequency identification, and indocyanine green are being integrated with surgical robots and navigation systems to guide surgeons for accurate lymph node mapping and removal.
Market Opportunities
Untapped emerging markets - Rising healthcare expenditure and growing medical tourism in countries such as India, China, and Brazil will drive the demand for sentinel node biopsy procedures in the coming years.
Personalized cancer care - Advancements in radiopharmaceuticals, surgical tools, and data analytics can enable more precise and personalized sentinel node biopsies based on individual patient and tumor characteristics.
Impact of COVID-19 on Sentinel Node Biopsy Market Growth
The COVID-19 pandemic has significantly impacted the global sentinel node biopsy market. During the initial phases of the pandemic, most elective surgical procedures including sentinel node biopsy were postponed to avoid virus transmission and prioritize critical care. This led to a steep decline in the volume of sentinel node biopsies performed globally in 2020. However, as restrictions eased in late 2020 and 2021, the market saw a steady recovery.
With more accurate risk assessment and safety protocols in place now, most healthcare facilities have resumed regular sentinel node biopsy services while taking necessary precautions. The demand is steadily reaching pre-COVID levels as patients who had deferred their procedures are getting biopsies done. Furthermore, the pandemic has heightened awareness about cancer diagnosis and treatment, benefitting the long term growth prospects of this market.
However, challenges of operating with limited resources and workforce shortages still persist in some regions. Supply chain disruptions caused by the pandemic also had brief negative impact. Overall, with enhanced protocols and vaccination drives in progress worldwide, the sentinel node biopsy market is expected to rebound fully and maintain its projected growth trajectory in the coming years.
Geographical Regions with High Sentinel Node Biopsy Market Value
North America accounts for the largest share of the global sentinel node biopsy market in terms of value. This is attributed to factors such as rising breast and melanoma cancer incidence, growing elderly population susceptible to cancer, and widespread health insurance coverage facilitating diagnostic procedures in the US and Canada. Furthermore, the region is an early adopter of novel technologies and surgical techniques related to cancer diagnosis and treatment. This provides an edge to North American market over other regions.
Europe is the second major lucrative region for sentinel node biopsy. High acceptability of personalized cancer treatment along with favorable reimbursement for minimally invasive procedures drive the European market. Asia Pacific is emerging as the fastest growing regional market owing to increasing affordability, growing public healthcare investment, and rising cancer burden in densely populated countries of China and India.
Fastest Growing Region - Asia Pacific
The Asia Pacific region holds immense growth potential for the sentinel node biopsy market driven by surging demand from economically advancing nations. Rapidly developing healthcare infrastructure, rising healthcare expenditures, growing geriatric population at risk of cancer are some key factors fueling the APAC market growth.
Furthermore, greater acceptability of Western diagnostic techniques paired with the establishment of more specialty cancer treatment centers presents an opportunity to reduce the treatment gap in the region. The presence of some of the most populated countries experiencing economic transformation such as China and India offers immense incremental opportunities.
Rising standards of living, increasing prioritization of cancer patient care, and supportive regulatory environment are further projected to aid the growth of sentinel node biopsy procedures in Asia Pacific region. It is expected to witness highest CAGR among other global regions during the forecast period.
Get more insights on, Sentinel Node Biopsy Market
Get This Report in Japanese Language:
Get This Report in Korean Language:
Explore More Related Article On- Medicinal Cannabis Market
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
Comments
0 comment